We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+14.63%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$905M
AUM Growth
+$139M
Cap. Flow
+$35.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
45.34%
Holding
1,131
New
35
Increased
129
Reduced
172
Closed
48

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.41M
2
MSFT icon
Microsoft
MSFT
+$5.02M
3
V icon
Visa
V
+$4.84M
4
AMZN icon
Amazon
AMZN
+$3.59M
5
KOS icon
Kosmos Energy
KOS
+$3.47M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$2.78M
2
NVDA icon
NVIDIA
NVDA
+$2.65M
3
MDLZ icon
Mondelez International
MDLZ
+$782K
4
EL icon
Estee Lauder
EL
+$772K
5
PFE icon
Pfizer
PFE
+$666K

Sector Composition

Rank Sector Weight
1 Financials 23.17%
2 Technology 17.19%
3 Consumer Discretionary 16.88%
4 Communication Services 11.83%
5 Healthcare 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GROW icon
1051
US Global Investors
GROW
$41.3M
$294 ﹤0.01%
270
– –
REGI
1052
DELISTED
Renewable Energy Group, Inc.
REGI
$264 ﹤0.01%
12
– –
ENFY
1053
DELISTED
Enlightify Inc
ENFY
$244 ﹤0.01%
42
– –
GALT icon
1054
Galectin Therapeutics
GALT
$405M
$204 ﹤0.01%
40
– –
ELOX
1055
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
– –
0
– –
QCLS
1056
Q/C Technologies Inc
QCLS
$19.2M
– –
0
– –
CRC
1057
DELISTED
California Resources Corporation
CRC
$129 ﹤0.01%
5
– –
SCPX
1058
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
KZIA
1059
Kazia Therapeutics
KZIA
$155M
$107 ﹤0.01%
1
– –
FAZ
1060
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
– –
0
– –
FRO icon
1061
Frontline
FRO
$9.84B
$90 ﹤0.01%
14
– –
TPST icon
1062
Tempest Therapeutics
TPST
$17.5M
– –
0
– –
BLRX
1063
BioLineRX
BLRX
$11.4M
– –
0
– –
SDRL
1064
DELISTED
Seadrill Limited Common Stock
SDRL
$75 ﹤0.01%
9
– –
GENE
1065
DELISTED
Genetic Technologies Ltd.
GENE
$71 ﹤0.01%
4
– –
GTE icon
1066
Gran Tierra Energy
GTE
$349M
$68 ﹤0.01%
3
– –
CRIS icon
1067
Curis
CRIS
$3.61M
– –
0
– –
SRL icon
1068
Scully Royalty
SRL
$88.9M
$59 ﹤0.01%
8
– –
GCVRZ
1069
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$59 ﹤0.01%
130
– –
NNVC icon
1070
NanoViricides
NNVC
$31.7M
$39 ﹤0.01%
7
– –
LSTA icon
1071
Lisata Therapeutics
LSTA
$15.2M
$36 ﹤0.01%
1
– –
OPTT icon
1072
Ocean Power Technologies
OPTT
$46.2M
$31 ﹤0.01%
7
– –
GRCE
1073
Grace Therapeutics
GRCE
$44.6M
$31 ﹤0.01%
1
– –
FCSC
1074
DELISTED
Fibrocell Science Inc.
FCSC
$27 ﹤0.01%
14
– –
SNOA icon
1075
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
0
– –
41 42
43
44 45

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q1 2019 Portfolio in Review

As of Q1 2019, RBC Europe held 1,131 positions worth $905M, up 18% from $767M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

RBC Europe deployed $35.2M of net new capital in Q1 2019, opening 35 new positions and adding to 129 existing holdings. Its largest new stake was Kosmos Energy: 626,188 shares worth $3.9M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Activision Blizzard, an estimated $2.78M trimmed.

  • RBC Europe's largest Q1 2019 buy was Kosmos Energy: 626,188 shares worth $3.9M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q1 2019, an estimated $9.41M increase.
  • RBC Europe's biggest Q1 2019 reduction was Activision Blizzard, cutting an estimated $2.78M.
  • RBC Europe fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $490K.
  • RBC Europe's ten largest holdings make up 45% of its $905M portfolio in Q1 2019.
  • RBC Europe opened 35 new positions and closed 48 in Q1 2019.
  • RBC Europe's portfolio value rose 18% quarter-over-quarter to $905M.

Based on RBC Europe's 13F filing for Q1 2019, filed 9 Nov 2023.